For the roughly one-in-three adults who live with prediabetes or elevated cardiovascular risk, diet remains the most accessible lever for metabolic change. This meta-analysis adds meaningful precision to what we already suspected about the Mediterranean diet — pinpointing exactly which blood markers shift, and which microbial species may be driving the effect.
Pooling nine randomized controlled trials enrolling 1,337 adults at elevated risk for type 2 diabetes or cardiovascular disease, the analysis found that Mediterranean diet interventions significantly reduced glycated hemoglobin (HbA1c) by a mean difference of −0.18 percentage points, LDL cholesterol by −0.10 mmol/L, and triglycerides by −0.20 mmol/L compared to control diets. Notably, fasting glucose, insulin, HOMA-IR, total cholesterol, and HDL cholesterol did not reach statistical significance — a nuance often lost in popular reporting on the Mediterranean diet. A qualitative synthesis of gut microbiota data across trials revealed increased alpha-diversity and enrichment of taxa associated with metabolic protection, including Akkermansia muciniphila and Roseburia spp., though methodological heterogeneity in sequencing techniques prevented formal meta-analysis of microbiome endpoints.
The HbA1c reduction of 0.18 percentage points, while modest in absolute terms, is clinically meaningful when applied across a population at risk. Prior research has established that each 0.1-point reduction in HbA1c correlates with measurable decreases in microvascular complication risk over time. What distinguishes this review is its simultaneous tracking of both metabolic and microbiome outcomes — an approach that begins to map a plausible gut-metabolic axis for the Mediterranean diet's protective effects. The enrichment of Akkermansia muciniphila is particularly noteworthy: this mucus-layer-associated bacterium has independently been linked to improved insulin sensitivity and reduced gut permeability in multiple human and animal models. The trial count of nine studies with under 1,400 total participants limits confidence in effect-size estimates, and the descriptive microbiome synthesis cannot establish causality between microbial shifts and metabolic improvements. Still, as a systematic review of RCTs — the gold standard study design — this represents a meaningful incremental advance that strengthens, rather than overturns, existing dietary guidance.